
1. retin cases brief rep. 2018 fall;12 suppl 1:s114-s117. doi:
10.1097/icb.0000000000000639.

cytomegalovirus retinitis associated occlusive vasculopathy elderly,
human immunodeficiency virus-negative man.

moussa k(1), doan t(1), stewart jm(1), shantha j(1), gonzales j(1), acharya n(1),
cunningham et jr(1)(2)(3)(4).

author information: 
(1)francis i. proctor foundation, department ophthalmology, university of
california, san francisco, san francisco, california.
(2)department ophthalmology, stanford university school medicine, palo
alto, california.
(3)department ophthalmology, california pacific medical center, san francisco,
california.
(4)west coast retina medical group, san francisco, california.

purpose: present case cytomegalovirus (cmv) retinitis associated with
occlusive vasculopathy presenting sudden unilateral loss vision human 
immunodeficiency virus-negative elderly man.
methods: clinical case report literature review.
results: 84-year-old chinese man diabetes mellitus primary open-angle
glaucoma seen consultation uveitis service evaluation sudden
vision loss right eye. examination revealed occlusive retinal
vasculopathy. extensive diagnostic workup performed, including fluorescein
angiography, serologic testing infectious etiologies including syphilis and
tuberculosis temporal artery biopsy. patient treated high-dose
oral prednisone, biopsy returned negative giant-cell
arteritis. three weeks initial presentation, patient noted 
a new area retinitis temporal periphery. anterior chamber
paracentesis performed, fluid sent directed polymerase chain 
reaction testing, returned positive cmv. human immunodeficiency virus
testing negative. treated oral valganciclovir intravitreal
foscarnet injections infection subsequently resolved.
conclusion: cytomegalovirus infection associated occlusive
vasculopathy human immunodeficiency virus-negative individuals. diagnosis 
of cmv retinitis considered patients human immunodeficiency
virus-negative conditions may compromise immune function,
particularly advanced age, diabetes mellitus, malignancy, use of
immunosuppressive agents.

doi: 10.1097/icb.0000000000000639 
pmcid: pmc7307742
pmid: 28937523  [indexed medline]

